Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Tripelennamine hydrochloride
Cat. No.:
OB0225LY-0161
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Tripelennamine hydrochloride is an antihistamine with low sedative effect.
Synonym:
Pyribenzamine hydrochloride; Tripelennamine HCl; Pyribenzamine HCl; 154-69-8; N1-Benzyl-N2,N2-dimethyl-N1-(pyridin-2-yl)ethane-1,2-diamine hydrochloride; N-Benzyl-N-[2-(dimethylamino)ethyl]pyridin-2-amine hydrochloride; N'-Benzyl-N, N-dimethyl-N'-pyridin-2-ylethane-1,2-diamine hydrochloride; N, N-Dimethyl-N-(phenylmethyl)-N-pyridin-2-ylethane-1,2-diamine hydrochloride; Pyribenzamine HCl
CAS No.:
154-69-8
Compound CID:
9066
Formula:
C16H21N3·HCl
Formula Weight:
291.82
Specification
Relative Density:
1.20 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Tripelennamine hydrochlorideCan be used for research and development of new allergy treatments.
Library Information
Targets:
Histamine receptor family
Receptors:
H1 receptor
Pathways:
Neuronal signaling; GPCR/G protein; Immunology/Inflammation
Plate Number:
AOCL-3
Plate Location:
a4
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
13 mg/mL; 44.55 mM
